Status:
COMPLETED
tDCS and Inhibitory Control in PTSD
Lead Sponsor:
Gopalkumar Rakesh
Conditions:
Post Traumatic Stress Disorder
Eligibility:
FEMALE
18-55 years
Phase:
NA
Brief Summary
Large samples (\~2,000/yr) of adult undergraduate students at a large southern university will be pre-screened via the University of Kentucky SONA System (IRB#43626) to identify and recruit adult fema...
Detailed Description
Inhibitory control deficits may be a hallmark neuropsychological feature of posttraumatic stress disorder (PTSD). Right inferior frontal gyrus (rIFG) activation is associated with stop signal reaction...
Eligibility Criteria
Inclusion
- Ability to provide informed consent
- Ability and willingness to perform procedures
- Age 18-55
- Female sex
- Meet diagnostic criteria for past-month probable IPV-related PTSD.
- Medication free or stable (≥4 weeks) medication(s)
Exclusion
- Unstable medical, psychiatric, or neurological condition that may necessitate urgent treatment
- Contraindications for tDCS
- History of psychosis, mania, major neurological disorder, significant head trauma, or epilepsy.
- Daily use of psychostimulant medication
- Daily use of medications that significantly lower seizure threshold
- Current suicidal intent
- History of seizures
- Current pregnancy
- Moderate severity substance-use disorder
Key Trial Info
Start Date :
October 27 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 4 2024
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT06100731
Start Date
October 27 2023
End Date
December 4 2024
Last Update
January 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kentucky
Lexington, Kentucky, United States, 40506